COVID-19 and HBP: High blood pressure (hypertension) greatly increases the risk of hospitalization for COVID-19 infection, even after a booster.
- High blood pressure (HBP) increases the risk for more severe COVID-19 illness
- People with high blood pressure (hypertension) are more likely to require hospitalization for severe COVID-19 illnesses such as Omicron infection, even after a booster
- Following COVID-19 protocols and avoiding the infection could save lives of people with HBP
Read More..
“The take-home message is that avoiding infection is extremely important—even when the circulating viral variant is presumed to cause mild disease in most people,” said Joseph E. Ebinger, MD, aClinical Cardiologist and Director of Clinical Analytics at the Smidt Heart Institute and first author of the study.
By reviewing electronic medical records, Cedars-Sinai investigators identified 912 people who were fully vaccinated with an mRNA vaccine, received a booster shot and were subsequently diagnosed with COVID-19 during the Omicron surge that occurred in Southern California from Dec. 1, 2021 through April 20, 2022. Of these individuals, 145 required hospitalization.
Risk Factors for Severe COVID-19 Infection
“We were surprised to learn that many people who were hospitalized with COVID-19 had hypertension and no other risk factors,” said Susan Cheng, MD, MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at the Smidt Heart Institute and a senior author of the study. “This is concerning when you consider that almost half of American adults have high blood pressure.”The team also found that chronic kidney disease, having had a heart attack, or heart failure, greatly increases the risk of hospitalization after infection.
Because, hypertension is common in people with chronic kidney disease, heart attack and heart failure, the investigators conducted an analysis that excluded patients diagnosed at some point with these conditions. The risk for hospitalization was still substantial for people diagnosed with hypertension alone.
These findings extend reports from early in the pandemic that also found associations between hypertension and severe COVID-19. Notably, researchers found that conditions such as obesity and diabetes, risk factors identified early in the pandemic, were not as strongly associated with hospitalization during the Omicron surge. The hypertension risk, however, persisted. More research is needed to understand the biological processes that may cause more severe COVID-19 illness in people with hypertension, and how to reduce this risk.
“Uncovering why hypertension is linked to COVID-19 could help us better understand how SARS-CoV-2 affects the body and provide clearer targets for prevention and treatment,” said Cheng, the Erika J. Glazer, Chair in Women's Cardiovascular Health and Population Science at Cedars-Sinai.
Meanwhile, people with hypertension who develop COVID-19 should be aware of their heightened risk for hospitalization and talk to their physician about antiviral therapy, according to Ebinger.
Reference:
1. Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination - (https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.122.19694)Source-Eurekalert